Eric M Dube
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $41.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 63,498465,054 held (−12%) | $61.99 | $3.9M | -15.9% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 28,796436,258 held (−6%) | $62.66 | $1.8M | -16.8% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 3,102433,156 held (−1%) | $63.64 | $197K | -18.1% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 270432,886 held (−0%) | $65.31 | $18K | -20.2% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 99,716529,011 held (−16%) | $63.26 | $6.3M | -17.6% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 96,125432,886 held (−18%) | $63.64 | $6.1M | -18.1% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 101,691439,688 held (−19%) | $64.59 | $6.6M | -19.3% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 6,802432,886 held (−2%) | $64.95 | $442K | -19.7% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 22,500432,886 held (−5%) | $43.95 | $989K | +18.6% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 56,815440,071 held (−11%) | $41.01 | $2.3M | +27.1% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 7,165432,906 held (−2%) | $41.75 | $299K | +24.9% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 20432,886 held (−0%) | $42.66 | $853 | +22.2% |
| Apr 2SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 34,902457,984 held (−7%) | $30.55 | $1.1M | +70.6% |
| Apr 2SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 25,098432,886 held (−5%) | $31.46 | $790K | +65.7% |
| Feb 24SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 60,000432,886 held (−12%) | $30.10 | $1.8M | +73.2% |
| Feb 3SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 66,452466,521 held (−12%) | $32.06 | $2.1M | +62.6% |
| Feb 3SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 33,635432,886 held (−7%) | $32.70 | $1.1M | +59.4% |
| Jan 27SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 8,135419,173 held (−2%) | $30.01 | $244K | +73.7% |
| Jan 27SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 51,865419,173 held (−11%) | $30.10 | $1.6M | +73.2% |
| Oct 30SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 92,872419,173 held (−18%) | $30.38 | $2.8M | +71.6% |
| Oct 30SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 27,128419,173 held (−6%) | $30.12 | $817K | +73.1% |
- Sell
CEO Eric M Dube sold $3.9M of TVTX at $61.99 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Eric M Dube sold $1.8M of TVTX at $62.66 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Eric M Dube sold $197K of TVTX at $63.64 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Eric M Dube sold $18K of TVTX at $65.31 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Eric M Dube sold $6.3M of TVTX at $63.26 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Eric M Dube sold $6.1M of TVTX at $63.64 — pre-scheduled 10b5-1 plan sale.